Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;26(3):211-8.
doi: 10.7555/JBR.26.20120011. Epub 2012 May 17.

Preliminary feasibility and hemodynamic performance of a newly-developed self-expanding bioprosthesis and 16-F delivery system in transcatheter aortic valve implantation in sheep

Affiliations

Preliminary feasibility and hemodynamic performance of a newly-developed self-expanding bioprosthesis and 16-F delivery system in transcatheter aortic valve implantation in sheep

Jing Cai et al. J Biomed Res. 2012 May.

Abstract

We sought to evaluate the feasibility and hemodynamic performance of a new self-expanding bioprosthesis and 16-F delivery system in sheep. A 23-mm new self-expanding aortic bioprosthesis was implanted in sheep (n = 10) with a 16-F catheter via the right common carotid artery. Each sheep underwent angiography and coronary angiography before intervention, immediately and 1 h after stent implantation. Electrocardiographic monitoring was carried out during and 2 h after the procedure. Transthoracic echocardiography was employed to detect hemodynamic performance before intervention, immediately and 1 and 2 h after stent implantation. All sheep were euthanized 2 h after successful implantation for macroscopic inspection. In all cases, the new self-expanding aortic bioprosthesis was successfully delivered to the aortic root and released with a 16-F catheter. Successful implantation was achieved in 8 of 10 sheep. Hemodynamic performance and device position of successful implantation were stable 2 h after device deployment. Atrioventricular block was not observed. We conclude that it is feasible to implant the new self-expanding aortic valve with a 16-F delivery system into sheep hearts via the retrograde route.

Keywords: aortic valve; percutaneous; self-expanding bioprothesis; sheep.

PubMed Disclaimer

Conflict of interest statement

The authors reported no conflict of interest.

Figures

Fig. 1
Fig. 1. The design of improved self-expanding bioprosthesis and its 16-F delivery system.
Fig. 2
Fig. 2. The supra-aortic angiogram after implantation of a valved stent.
Angiography confirmed the well-anchored position of the device without evidence of aortic regurgitation or obstruction of coronary blood flow (arrows). In this case, we detected mild paravalvular aortic regurgitation after device deployment, but we selected this figure with no aortic regurgitation for clear visualization of coronary blood flow.
Fig. 3
Fig. 3. Echocardiographic image of a 23-mm device implanted into an aortic root with a 19.1-mm aortic annulus (2 h post procedure).
Echocardiography showed that the device was in a good position and functioned normally. A: Long-axis, the stent (arrows) showed strong echo signals (LA=left atrium, LVOT=left ventricular outflow tract). B: Short-axis, the right coronary sinus (arrow) and left coronary sinus (arrowhead) were unaffected.
Fig. 4
Fig. 4. Gross anatomy after successful implantation of the device.
The stent “fingerprint” on the aortic wall indicated high radial expansion of the stent.
Fig. 5
Fig. 5. Echocardiographic image of moderate paravalvular aortic regurgitation after a 20-mm bioprothesis into an aortic root with a 19.6-mm native aortic annulus (long-axis, 2 h post procedure).
A: An increased trans-aortic gradient (15.1 mmHg vs 3.6 mmHg pre-procedure) and moderate paravalvular aortic regurgitation were observed. B: Echocardiography showed that there was a gap between the device and the left ventricular outflow wall (arrow).

Similar articles

Cited by

References

    1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a populationbased study. Lancet. 2006;368:1005–11. - PubMed
    1. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–20. - PubMed
    1. Dal-Bianco JP, Khandheria BK, Mookadam F, Gentile F, Sengupta PP. Management of asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2008;52:1279–92. - PubMed
    1. Routledge HC, Lefevre T, Morice MC, DeMarco F, Salmi L, Cormier B. Percutaneous aortic valve replacement: New hope for inoperable and high-risk patients. J Invasive Cardiol. 2007;19:478–83. - PubMed
    1. Cribier A, Savin T, Berland J, Rocha P, Mechmeche R, Saoudi N, et al. Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. J Am Coll Cardiol. 1987;9:381–6. - PubMed